Hikma Pharmaceuticals PLC (HIK) — Net Asset Quality Index
Hikma Pharmaceuticals PLC (HIK) has a Net Asset Quality Index of 45.9% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX5.55 Billion minus total liabilities of GBX3.00 Billion yields net assets of GBX2.55 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Hikma Pharmaceuticals PLC defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Hikma Pharmaceuticals PLC Net Asset Quality Index Over Time (2002–2024)
This chart shows how Hikma Pharmaceuticals PLC's Net Asset Quality Index has evolved across 23 annual periods from 2002 to 2024. As of June 2025, the index stands at 45.9%, representing net assets of GBX2.55 Billion against total assets of GBX5.55 Billion GBX. Explore HIK cash flow metrics to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Hikma Pharmaceuticals PLC (2002–2024)
The table below presents the year-by-year Net Asset Quality Index for Hikma Pharmaceuticals PLC from 2002 to 2024, covering 23 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see HIK market cap overview.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 45.2% | GBX2.32 Billion | GBX5.13 Billion | GBX2.81 Billion | ▼ -2.0 pp |
| 2023 | 47.2% | GBX2.21 Billion | GBX4.68 Billion | GBX2.47 Billion | ▼ -0.8 pp |
| 2022 | 48.0% | GBX2.15 Billion | GBX4.47 Billion | GBX2.32 Billion | ▼ -8.4 pp |
| 2021 | 56.4% | GBX2.47 Billion | GBX4.37 Billion | GBX1.91 Billion | ▲ +4.5 pp |
| 2020 | 51.9% | GBX2.15 Billion | GBX4.13 Billion | GBX1.99 Billion | ▼ -2.2 pp |
| 2019 | 54.2% | GBX2.13 Billion | GBX3.93 Billion | GBX1.80 Billion | ▲ +5.6 pp |
| 2018 | 48.5% | GBX1.70 Billion | GBX3.50 Billion | GBX1.80 Billion | ▲ +3.4 pp |
| 2017 | 45.1% | GBX1.53 Billion | GBX3.39 Billion | GBX1.86 Billion | ▼ -10.2 pp |
| 2016 | 55.3% | GBX2.41 Billion | GBX4.36 Billion | GBX1.95 Billion | ▲ +3.2 pp |
| 2015 | 52.1% | GBX1.35 Billion | GBX2.60 Billion | GBX1.25 Billion | ▼ -2.0 pp |
| 2014 | 54.0% | GBX1.22 Billion | GBX2.25 Billion | GBX1.03 Billion | ▲ +0.4 pp |
| 2013 | 53.6% | GBX1.03 Billion | GBX1.93 Billion | GBX895.00 Million | ▲ +4.6 pp |
| 2012 | 49.0% | GBX847.85 Million | GBX1.73 Billion | GBX882.26 Million | ▼ -1.7 pp |
| 2011 | 50.7% | GBX798.63 Million | GBX1.58 Billion | GBX777.01 Million | ▼ -16.6 pp |
| 2010 | 67.2% | GBX750.30 Million | GBX1.12 Billion | GBX365.52 Million | ▲ +0.4 pp |
| 2009 | 66.8% | GBX683.26 Million | GBX1.02 Billion | GBX339.46 Million | ▲ +3.8 pp |
| 2008 | 63.0% | GBX609.00 Million | GBX966.46 Million | GBX357.46 Million | ▲ +15.5 pp |
| 2007 | 47.5% | GBX424.66 Million | GBX894.04 Million | GBX469.38 Million | ▼ -24.1 pp |
| 2006 | 71.6% | GBX349.80 Million | GBX488.36 Million | GBX138.56 Million | ▼ -0.6 pp |
| 2005 | 72.2% | GBX287.48 Million | GBX397.96 Million | GBX110.48 Million | ▲ +13.3 pp |
| 2004 | 58.9% | GBX145.18 Million | GBX246.48 Million | GBX101.31 Million | ▲ +7.6 pp |
| 2003 | 51.3% | GBX60.47 Million | GBX117.86 Million | GBX57.39 Million | ▲ +0.7 pp |
| 2002 | 50.6% | GBX48.03 Million | GBX94.86 Million | GBX46.84 Million | — |